China Antibody Drug Conjugates Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Antibody drug conjugate (ADC) are essentially anti-cancer drugs. ADC has broad application in prostate cancer, skin cancer, leukemia, pancreatic cancer, lymphoma, renal cancer, ovarian cancer, colon cancer, multiple myeloma, lung cancer, breast cancer, glioblastoma and other cancer types.

    The Americas will lead the market over the forecast period. The contribution of nanotechnology to the development of antibody drug conjugates (ADC), manufacturing processes and technological advances have contributed to the growth of the global antibody drug conjugate market in this region. The global demand for Antibody Drug Conjugates Market is expected to generate revenue of around USD 2863.51 Million by end of 2026, growing at a CAGR of around 7.3 % between 2020 and 2026.

    Advances in medical technology, increased cancer rates, and increased obesity are all factors that are driving the market for antibody drug conjugates. In addition, the growing cooperation between biopharmaceuticals and research institutions will also play a role in promoting the development of antibody drug conjugates market.

    This report elaborates on the current development of the Antibody Drug Conjugates industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pfizer

    • F Hoffman-La Roche

    • Progenics Pharmaceuticals

    • Genentech

    • Bayer Healthcare Pharmaceuticals

    • Takeda Pharmaceutical

    • Immunogen

    • Seattle Genetics

    By Type:

    • Adcertis

    • Kadcyla

    By Application:

    • Lung Cancer

    • Ovarian Cancer

    • others

    • Brain Tumor

    • Breast Cancer

    • Blood Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Antibody Drug Conjugates Market Overview 2018-2029

    • 1.1 China Antibody Drug Conjugates Industry Development Overview

    • 1.2 China Antibody Drug Conjugates Industry Development History

    • 1.3 China Antibody Drug Conjugates Industry Market Size (2018-2029)

    • 1.4 China Antibody Drug Conjugates Market Analysis by Type from Production Side

      • 1.4.1 China Antibody Drug Conjugates Production Volume, Production Value and Growth Rate of Adcertis (2018-2029)

      • 1.4.2 China Antibody Drug Conjugates Production Volume, Production Value and Growth Rate of Kadcyla (2018-2029)

    • 1.5 China Antibody Drug Conjugates Market Analysis by Application from Consumption End

      • 1.5.1 China Antibody Drug Conjugates Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

      • 1.5.2 China Antibody Drug Conjugates Sales Volume, Sales Value and Growth Rate of Ovarian Cancer (2018-2029)

      • 1.5.3 China Antibody Drug Conjugates Sales Volume, Sales Value and Growth Rate of others (2018-2029)

      • 1.5.4 China Antibody Drug Conjugates Sales Volume, Sales Value and Growth Rate of Brain Tumor (2018-2029)

      • 1.5.5 China Antibody Drug Conjugates Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

      • 1.5.6 China Antibody Drug Conjugates Sales Volume, Sales Value and Growth Rate of Blood Cancer (2018-2029)

    • 1.6 China Antibody Drug Conjugates Market Analysis by Region

      • 1.6.1 North China Antibody Drug Conjugates Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Antibody Drug Conjugates Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Antibody Drug Conjugates Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Antibody Drug Conjugates Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Antibody Drug Conjugates Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Antibody Drug Conjugates Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Antibody Drug Conjugates Market Size and Growth Rate from 2018-2029

    Chapter 2 China Antibody Drug Conjugates Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Antibody Drug Conjugates Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Antibody Drug Conjugates Market Status and Competition Analysis in 2023

      • 2.2.3 China Antibody Drug Conjugates Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Antibody Drug Conjugates Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Antibody Drug Conjugates Industry Development

    Chapter 3 Antibody Drug ConjugatesIndustry Chain Analysis

    • 3.1 Antibody Drug Conjugates Industry Chain

    • 3.2 Antibody Drug Conjugates Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Antibody Drug Conjugates Market

    • 3.3 Antibody Drug Conjugates Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Antibody Drug Conjugates Market

    Chapter 4 China Antibody Drug Conjugates Market, by Type

    • 4.1 China Antibody Drug Conjugates Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Antibody Drug Conjugates Total Production Volume and Growth Rate from Production Side

    • 4.5 China Antibody Drug Conjugates Production Volume and Growth Rate, by Type

      • 4.5.1 China Antibody Drug Conjugates Production Volume and Growth Rate of Adcertis

      • 4.5.2 China Antibody Drug Conjugates Production Volume and Growth Rate of Kadcyla

    Chapter 5 China Antibody Drug Conjugates Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Antibody Drug Conjugates Total Market Size and Growth Rate from Consumption End

    • 5.5 China Antibody Drug Conjugates Market Size and Growth Rate, by Application

      • 5.5.1 China Antibody Drug Conjugates Market Size and Growth Rate of Lung Cancer

      • 5.5.2 China Antibody Drug Conjugates Market Size and Growth Rate of Ovarian Cancer

      • 5.5.3 China Antibody Drug Conjugates Market Size and Growth Rate of others

      • 5.5.4 China Antibody Drug Conjugates Market Size and Growth Rate of Brain Tumor

      • 5.5.5 China Antibody Drug Conjugates Market Size and Growth Rate of Breast Cancer

      • 5.5.6 China Antibody Drug Conjugates Market Size and Growth Rate of Blood Cancer

    Chapter 6 China Antibody Drug Conjugates Market, by Region

    • 6.1 China Antibody Drug Conjugates Production Volume and Production Value, by Region

    • 6.2 China Antibody Drug Conjugates Sales Volume and Sales Value, by Region

    Chapter 7 North China Antibody Drug Conjugates Market Analysis

    • 7.1 North China Antibody Drug Conjugates Market, by Type

    • 7.2 North China Antibody Drug Conjugates Market, by Application

    Chapter 8 Central China Antibody Drug Conjugates Market Analysis

    • 8.1 Central China Antibody Drug Conjugates Market, by Type

    • 8.2 Central China Antibody Drug Conjugates Market, by Application

    Chapter 9 South China Antibody Drug Conjugates Market Analysis

    • 9.1 South China Antibody Drug Conjugates Market, by Type

    • 9.2 South China Antibody Drug Conjugates Market, by Application

    Chapter 10 East China Antibody Drug Conjugates Market Analysis

    • 10.1 East China Antibody Drug Conjugates Market, by Type

    • 10.2 East China Antibody Drug Conjugates Market, by Application

    Chapter 11 Northeast China Antibody Drug Conjugates Market Analysis

    • 11.1 Northeast China Antibody Drug Conjugates Market, by Type

    • 11.2 Northeast China Antibody Drug Conjugates Market, by Application

    Chapter 12 Southwest China Antibody Drug Conjugates Market Analysis

    • 12.1 Southwest China Antibody Drug Conjugates Market, by Type

    • 12.2 Southwest China Antibody Drug Conjugates Market, by Application

    Chapter 13 Northwest China Antibody Drug Conjugates Market Analysis

    • 13.1 Northwest China Antibody Drug Conjugates Market, by Type

    • 13.2 Northwest China Antibody Drug Conjugates Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pfizer

        • 14.1.1 Pfizer Company Profile

        • 14.1.2 Pfizer Antibody Drug Conjugates Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 F Hoffman-La Roche

        • 14.2.1 F Hoffman-La Roche Company Profile

        • 14.2.2 F Hoffman-La Roche Antibody Drug Conjugates Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Progenics Pharmaceuticals

        • 14.3.1 Progenics Pharmaceuticals Company Profile

        • 14.3.2 Progenics Pharmaceuticals Antibody Drug Conjugates Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Genentech

        • 14.4.1 Genentech Company Profile

        • 14.4.2 Genentech Antibody Drug Conjugates Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Bayer Healthcare Pharmaceuticals

        • 14.5.1 Bayer Healthcare Pharmaceuticals Company Profile

        • 14.5.2 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Takeda Pharmaceutical

        • 14.6.1 Takeda Pharmaceutical Company Profile

        • 14.6.2 Takeda Pharmaceutical Antibody Drug Conjugates Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Immunogen

        • 14.7.1 Immunogen Company Profile

        • 14.7.2 Immunogen Antibody Drug Conjugates Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Seattle Genetics

        • 14.8.1 Seattle Genetics Company Profile

        • 14.8.2 Seattle Genetics Antibody Drug Conjugates Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Antibody Drug Conjugates Industry Research Conclusions

    • 15.2 Antibody Drug Conjugates Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Antibody Drug Conjugates Industry Market Size (2018-2029)

    • Figure China Antibody Drug Conjugates Production Volume, Production Value and Growth Rate of Adcertis (2018-2029)

    • Figure China Antibody Drug Conjugates Production Volume, Production Value and Growth Rate of Kadcyla (2018-2029)

    • Figure China Antibody Drug Conjugates Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

    • Figure China Antibody Drug Conjugates Sales Volume, Sales Value and Growth Rate of Ovarian Cancer (2018-2029)

    • Figure China Antibody Drug Conjugates Sales Volume, Sales Value and Growth Rate of others (2018-2029)

    • Figure China Antibody Drug Conjugates Sales Volume, Sales Value and Growth Rate of Brain Tumor (2018-2029)

    • Figure China Antibody Drug Conjugates Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure China Antibody Drug Conjugates Sales Volume, Sales Value and Growth Rate of Blood Cancer (2018-2029)

    • Figure North China Antibody Drug Conjugates Market Size and Growth Rate from 2018-2029

    • Figure Central China Antibody Drug Conjugates Market Size and Growth Rate from 2018-2029

    • Figure South China Antibody Drug Conjugates Market Size and Growth Rate from 2018-2029

    • Figure East China Antibody Drug Conjugates Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Antibody Drug Conjugates Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Antibody Drug Conjugates Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Antibody Drug Conjugates Market Size and Growth Rate from 2018-2029

    • Figure Antibody Drug Conjugates Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Antibody Drug Conjugates Market Share by Type in 2018

    • Figure China Antibody Drug Conjugates Market Share by Type in 2023

    • Figure China Antibody Drug Conjugates Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Antibody Drug Conjugates Production Volume and Growth Rate of Adcertis (2018-2023)

    • Figure China Antibody Drug Conjugates Production Volume and Growth Rate of Kadcyla (2018-2023)

    • Figure China Antibody Drug Conjugates Market Share by Application in 2018

    • Figure China Antibody Drug Conjugates Market Share by Application in 2023

    • Figure China Antibody Drug Conjugates Total Market Size and Growth Rate from Consumption End

    • Figure China Antibody Drug Conjugates Market Size and Growth Rate of Lung Cancer (2018-2023)

    • Figure China Antibody Drug Conjugates Market Size and Growth Rate of Ovarian Cancer (2018-2023)

    • Figure China Antibody Drug Conjugates Market Size and Growth Rate of others (2018-2023)

    • Figure China Antibody Drug Conjugates Market Size and Growth Rate of Brain Tumor (2018-2023)

    • Figure China Antibody Drug Conjugates Market Size and Growth Rate of Breast Cancer (2018-2023)

    • Figure China Antibody Drug Conjugates Market Size and Growth Rate of Blood Cancer (2018-2023)

    • Table China Antibody Drug Conjugates Production Volume by Region (2018-2023)

    • Table China Antibody Drug Conjugates Production Volume Share by Region (2018-2023)

    • Figure China Antibody Drug Conjugates Production Volume Share by Region (2018-2023)

    • Table China Antibody Drug Conjugates Production Value by Region (2018-2023)

    • Table China Antibody Drug Conjugates Production Value Share by Region (2018-2023)

    • Figure China Antibody Drug Conjugates Production Value Share by Region (2018-2023)

    • Table China Antibody Drug Conjugates Sales Volume by Region (2018-2023)

    • Table China Antibody Drug Conjugates Sales Volume Share by Region (2018-2023)

    • Figure China Antibody Drug Conjugates Sales Volume Share by Region (2018-2023)

    • Table China Antibody Drug Conjugates Sales Value by Region (2018-2023)

    • Table China Antibody Drug Conjugates Sales Value Share by Region (2018-2023)

    • Figure China Antibody Drug Conjugates Sales Value Share by Region (2018-2023)

    • Table North China Antibody Drug Conjugates Production Volume by Type (2018-2023)

    • Table North China Antibody Drug Conjugates Production Volume Share by Type (2018-2023)

    • Figure North China Antibody Drug Conjugates Production Volume Share by Type (2018-2023)

    • Table North China Antibody Drug Conjugates Sales Volume by Application (2018-2023)

    • Table North China Antibody Drug Conjugates Sales Volume Share by Application (2018-2023)

    • Figure North China Antibody Drug Conjugates Sales Volume Share by Application (2018-2023)

    • Table Central China Antibody Drug Conjugates Production Volume by Type (2018-2023)

    • Table Central China Antibody Drug Conjugates Production Volume Share by Type (2018-2023)

    • Figure Central China Antibody Drug Conjugates Production Volume Share by Type (2018-2023)

    • Table Central China Antibody Drug Conjugates Sales Volume by Application (2018-2023)

    • Table Central China Antibody Drug Conjugates Sales Volume Share by Application (2018-2023)

    • Figure Central China Antibody Drug Conjugates Sales Volume Share by Application (2018-2023)

    • Table South China Antibody Drug Conjugates Production Volume by Type (2018-2023)

    • Table South China Antibody Drug Conjugates Production Volume Share by Type (2018-2023)

    • Figure South China Antibody Drug Conjugates Production Volume Share by Type (2018-2023)

    • Table South China Antibody Drug Conjugates Sales Volume by Application (2018-2023)

    • Table South China Antibody Drug Conjugates Sales Volume Share by Application (2018-2023)

    • Figure South China Antibody Drug Conjugates Sales Volume Share by Application (2018-2023)

    • Table East China Antibody Drug Conjugates Production Volume by Type (2018-2023)

    • Table East China Antibody Drug Conjugates Production Volume Share by Type (2018-2023)

    • Figure East China Antibody Drug Conjugates Production Volume Share by Type (2018-2023)

    • Table East China Antibody Drug Conjugates Sales Volume by Application (2018-2023)

    • Table East China Antibody Drug Conjugates Sales Volume Share by Application (2018-2023)

    • Figure East China Antibody Drug Conjugates Sales Volume Share by Application (2018-2023)

    • Table Northeast China Antibody Drug Conjugates Production Volume by Type (2018-2023)

    • Table Northeast China Antibody Drug Conjugates Production Volume Share by Type (2018-2023)

    • Figure Northeast China Antibody Drug Conjugates Production Volume Share by Type (2018-2023)

    • Table Northeast China Antibody Drug Conjugates Sales Volume by Application (2018-2023)

    • Table Northeast China Antibody Drug Conjugates Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Antibody Drug Conjugates Sales Volume Share by Application (2018-2023)

    • Table Southwest China Antibody Drug Conjugates Production Volume by Type (2018-2023)

    • Table Southwest China Antibody Drug Conjugates Production Volume Share by Type (2018-2023)

    • Figure Southwest China Antibody Drug Conjugates Production Volume Share by Type (2018-2023)

    • Table Southwest China Antibody Drug Conjugates Sales Volume by Application (2018-2023)

    • Table Southwest China Antibody Drug Conjugates Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Antibody Drug Conjugates Sales Volume Share by Application (2018-2023)

    • Table Northwest China Antibody Drug Conjugates Production Volume by Type (2018-2023)

    • Table Northwest China Antibody Drug Conjugates Production Volume Share by Type (2018-2023)

    • Figure Northwest China Antibody Drug Conjugates Production Volume Share by Type (2018-2023)

    • Table Northwest China Antibody Drug Conjugates Sales Volume by Application (2018-2023)

    • Table Northwest China Antibody Drug Conjugates Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Antibody Drug Conjugates Sales Volume Share by Application (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Antibody Drug Conjugates Revenue, Price and Gross (2018-2023)

    • Table F Hoffman-La Roche Company Profile

    • Table F Hoffman-La Roche Antibody Drug Conjugates Revenue, Price and Gross (2018-2023)

    • Table Progenics Pharmaceuticals Company Profile

    • Table Progenics Pharmaceuticals Antibody Drug Conjugates Revenue, Price and Gross (2018-2023)

    • Table Genentech Company Profile

    • Table Genentech Antibody Drug Conjugates Revenue, Price and Gross (2018-2023)

    • Table Bayer Healthcare Pharmaceuticals Company Profile

    • Table Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Company Profile

    • Table Takeda Pharmaceutical Antibody Drug Conjugates Revenue, Price and Gross (2018-2023)

    • Table Immunogen Company Profile

    • Table Immunogen Antibody Drug Conjugates Revenue, Price and Gross (2018-2023)

    • Table Seattle Genetics Company Profile

    • Table Seattle Genetics Antibody Drug Conjugates Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.